[ Price : $8.95]
The House approves drug pricing legislation that is likely to die in the Senate or face a presidential veto.[ Price : $8.95]
Provention Bio says it is planning a rolling BLA application for its Type 1 diabetes drug teplizumab in 2020.[ Price : $8.95]
FDA publishes for comment a draft guidance on early planning for pediatric evaluation of certain molecularly targeted oncology dru...[ Price : $8.95]
Attorney Michelle Yeary says a DC federal court decision might open the way for FDA Warning Letters to be considered final agency ...[ Price : $8.95]
The Council for Responsible Nutrition praises the Supreme Courts refusal to hear an Amrin appeal of a fish oil dietary supplement ...[ Price : $8.95]
Federal Register notice: FDA has determined for patent extension purposes the regulatory review period for Briviact oral solution ...[ Price : $8.95]
FDA clears a Cochlear Ltd. 510(k) for the Cochlear Osia 2 System, an active osseointegrated steady-state hearing implant.[ Price : $8.95]
The CDER Office of Prescription Drug Promotion warns Alkermes about a misleading Vivitrol print ad that omits important risk infor...